Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details
A deep dive into a French study shows the benefit was seen in older, sicker patients who were at high risk for surgery.
A deep dive into a French study shows the benefit was seen in older, sicker patients who were at high risk for surgery.
This study performs a systematic review to identify which types of system-level initiatives are most effective at improving guideline-directed medical therapy use among patients with…
No study has assessed durability of pulmonary vein isolation (PVI) with radiofrequency (RF) and Cryoballoon (CB) in patients with persistent AF. These data are especially…
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
People who live in rural areas get sicker and die sooner than people in urban areas. But the American Heart Association – working with people…
Spending time with your pet can be relaxing, encouraging the release of endorphins.
This cohort study evaluates recent reversals in declines in cardiovascular mortality and whether they vary across sociodemographic categories.
Interested in finding out how the late-breaking science presented at SCAI 2024 will impact your practice? Our experts distilled what you need to know: A…
The benefit of catheter ablation in patients with atrial fibrillation (AF) for patients with heart failure with preserved ejection fraction (HFpEF) remains uncertain.
CardioSmart infographics are designed for use as handouts or posters in care settings and local community centers.
The National Blood Clot Alliance is an official charity partner of the TD Five Boro Bike Tour, hosted by Bike New York. Blood clots can…